Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Filings indexed 245 across all filing types
Latest filing 2026-06-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a "주식등의 대량보유상황보고서(일반)" (Report on Large Holdings of Shares) filed under the Korean Capital Markets Act. It discloses detailed shareholdings of the reporting person and related parties, changes in holdings including provisions of share options, collateral, and voting rights. This corresponds to a notification of changes in a significant share ownership level crossing reportable thresholds, matching the definition of Major Shareholding Notification (MRQ).
2026-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean statutory ownership report filed by an executive (Kim Seong-hwan) disclosing his personal shareholdings and changes (stock option exercise, share counts, percentages). This is a personal insider transaction disclosure by a director/executive, fitting the “Director’s Dealing” category.
2026-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ filed with the Securities and Futures Commission and Korea Exchange, detailing an officer’s personal share/security ownership and changes (stock option exercise). This is a disclosure of insider transactions by a company director, matching the ‘Director’s Dealing’ category rather than a corporate buyback. Therefore, it is classified as DIRS.
2026-06-08 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 60% confidence The document is a formal announcement of an upcoming investor relations meeting (IR event) with schedule and logistics, not the actual presentation content or slide deck. It does not contain financial data or slides, nor is it a report release notice. Such event notices are general regulatory announcements. Therefore, it best fits the Regulatory Filings (RNS) category.
2026-06-02 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (VRN110755의 제 1/2상 임상시험)
Regulatory Filings Classification · 78% confidence The document is a Korean regulatory disclosure (‘정정신고’) reporting a correction to a prior announcement regarding clinical trial plan change approvals. It contains no financial statements or investor presentation content, but rather an operational compliance update under listing rules. This fits the generic “Regulatory Filings (RNS)” category as a fallback for miscellaneous regulatory announcements.
2026-05-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean ‘주식등의 대량보유상황보고서(일반)’ – literally a ‘Report of Large Shareholding (General)’ under the Capital Markets Act. It details the holdings and changes in holdings of a major shareholder (including contract extensions, collateral arrangements, voting rights), matching the definition of a Major Shareholding Notification rather than a financial report or earnings release. Thus it falls under the Major Shareholding Notification category.
2026-05-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.